• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏消除的弥散模型:1. 模型的建立及大剂量注射的考量

A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

作者信息

Roberts M S, Rowland M

出版信息

J Pharmacokinet Biopharm. 1986 Jun;14(3):227-60. doi: 10.1007/BF01106706.

DOI:10.1007/BF01106706
PMID:3783446
Abstract

A dispersion model of hepatic elimination, based on the residence time distribution of blood elements within the liver, is presented. The general rate equations appropriate for describing the hepatic output concentration of a tracer solute are derived. Particular consideration is given to events following a bolus input dose of a tracer. The model is shown to be compatible with the known hepatic architecture and hepatic physiology. The model has been fitted to hepatic outflow data for red blood cells, albumin, and other noneliminated solutes. The experimental data suggest a high degree of dispersion of blood elements within the liver. The model has also been used to evaluate the effects of changes in enzyme activity, hepatic cell permeability, blood flow, and protein binding on the outflow concentration vs. time profiles of solutes.

摘要

本文提出了一种基于肝脏内血液成分停留时间分布的肝脏消除弥散模型。推导了适用于描述示踪溶质肝脏输出浓度的一般速率方程。特别考虑了示踪剂单次静脉注射剂量后的情况。该模型与已知的肝脏结构和肝脏生理学相符。该模型已被拟合到红细胞、白蛋白和其他非消除性溶质的肝脏流出数据。实验数据表明肝脏内血液成分存在高度弥散。该模型还被用于评估酶活性、肝细胞通透性、血流量和蛋白质结合的变化对溶质流出浓度与时间曲线的影响。

相似文献

1
A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.肝脏消除的弥散模型:1. 模型的建立及大剂量注射的考量
J Pharmacokinet Biopharm. 1986 Jun;14(3):227-60. doi: 10.1007/BF01106706.
2
A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.肝脏消除的弥散模型:2. 稳态考量——肝血流量、血液内结合以及肝细胞酶活性的影响
J Pharmacokinet Biopharm. 1986 Jun;14(3):261-88. doi: 10.1007/BF01106707.
3
A dispersion model of hepatic elimination: 3. Application to metabolite formation and elimination kinetics.
J Pharmacokinet Biopharm. 1986 Jun;14(3):289-308. doi: 10.1007/BF01106708.
4
Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.
J Pharmacokinet Biopharm. 1988 Feb;16(1):41-83. doi: 10.1007/BF01061862.
5
Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.肝药物消除轴向扩散模型在离体灌注大鼠肝脏中地西泮动力学的应用。
J Pharmacokinet Biopharm. 1992 Apr;20(2):171-93. doi: 10.1007/BF01071000.
6
Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.用扩展对流扩散模型对肝脏消除和器官分布动力学进行建模。
J Pharmacokinet Biopharm. 1999 Aug;27(4):343-82. doi: 10.1023/a:1020992421184.
7
Effect of plasma protein binding on elimination of taurocholate by isolated perfused rat liver: comparison of venous equilibrium, undistributed and distributed sinusoidal, and dispersion models.血浆蛋白结合对离体灌注大鼠肝脏消除牛磺胆酸盐的影响:静脉平衡、非分布和分布性肝血窦以及弥散模型的比较
J Pharmacokinet Biopharm. 1988 Aug;16(4):377-96. doi: 10.1007/BF01062552.
8
Hepatic elimination of drugs with concentration-dependent serum protein binding.肝脏对具有浓度依赖性血清蛋白结合的药物的消除作用。
J Pharmacokinet Biopharm. 1984 Feb;12(1):67-81. doi: 10.1007/BF01063611.
9
A new model-independent physiological approach to study hepatic drug clearance and its applications.一种用于研究肝脏药物清除率的新型非模型依赖生理学方法及其应用。
Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):577-90.
10
Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.使用肝脏消除的弥散模型研究溶质在灌注大鼠肝脏中的停留时间分布:1. 灌注液流量和白蛋白浓度变化对蔗糖和牛磺胆酸盐的影响
J Pharmacokinet Biopharm. 1990 Jun;18(3):209-34. doi: 10.1007/BF01062200.

引用本文的文献

1
Breadth of Pharmacology Modeling: Fundamentals of Pharmacokinetics, Pharmacodynamics, and Mechanistic Modeling.
Handb Exp Pharmacol. 2025;289:21-73. doi: 10.1007/164_2025_746.
2
Diffusion dimensionality modeling of subcutaneous/intramuscular absorption of antibodies and long-acting injectables.抗体及长效注射剂皮下/肌肉注射吸收的扩散维度建模
J Pharmacokinet Pharmacodyn. 2025 Apr 22;52(3):26. doi: 10.1007/s10928-025-09973-8.
3
Changes in Plasma Clearance of CYP450 Probe Drugs May Not be Specific for Altered In Vivo Enzyme Activity Under (Patho)Physiological Conditions: How to Interpret Findings of Probe Cocktail Studies.在(病理)生理条件下,CYP450 探针药物的血浆清除率的变化可能不能特异性地反映体内酶活性的改变:如何解释探针鸡尾酒研究的结果。

本文引用的文献

1
A linear method for determining liver sinusoidal and extravascular volumes.一种用于确定肝窦和血管外容积的线性方法。
Am J Physiol. 1963 Apr;204:626-40. doi: 10.1152/ajplegacy.1963.204.4.626.
2
Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivative.胆汁酸衍生物肝小叶浓度梯度的放射自显影证据。
Am J Physiol. 1980 Mar;238(3):G233-7. doi: 10.1152/ajpgi.1980.238.3.G233.
3
Moments of physiological transit time distributions and the time course of drug disposition in the body.生理转运时间分布的时刻以及药物在体内处置的时间进程。
Clin Pharmacokinet. 2024 Nov;63(11):1585-1595. doi: 10.1007/s40262-024-01426-8. Epub 2024 Oct 27.
4
Predicting Clearance with Simple and Permeability-Limited Physiologically Based Pharmacokinetic Frameworks: Comparison of Well-Stirred, Dispersion, and Parallel-Tube Liver Models.运用简单且具有通透性限制的生理药代动力学框架预测清除率:搅拌池、弥散和并行管肝脏模型的比较。
Drug Metab Dispos. 2024 Sep 16;52(10):1060-1072. doi: 10.1124/dmd.124.001782.
5
Hepatic OATP1B zonal distribution: Implications for rifampicin-mediated drug-drug interactions explored within a PBPK framework.肝外排转运蛋白 1B 区域性分布:在 PBPK 框架内探讨利福平介导的药物-药物相互作用的意义。
CPT Pharmacometrics Syst Pharmacol. 2024 Sep;13(9):1513-1527. doi: 10.1002/psp4.13188. Epub 2024 Jun 19.
6
The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment.基于生理学的毒代动力学模型在健康风险评估中的应用。
Toxics. 2023 Oct 21;11(10):874. doi: 10.3390/toxics11100874.
7
Unraveling the Effects of Acute Inflammation on Pharmacokinetics: A Model-Based Analysis Focusing on Renal Glomerular Filtration Rate and Cytochrome P450 3A4-Mediated Metabolism.解析急性炎症对药代动力学的影响:基于模型的分析,重点关注肾小球滤过率和细胞色素 P4503A4 介导的代谢。
Eur J Drug Metab Pharmacokinet. 2023 Nov;48(6):623-631. doi: 10.1007/s13318-023-00852-6. Epub 2023 Sep 15.
8
Utility of Minimal Physiologically Based Pharmacokinetic Models for Assessing Fractional Distribution, Oral Absorption, and Series-Compartment Models of Hepatic Clearance.最小生理基于药代动力学模型在评估分数分布、口服吸收和肝脏清除的串联房室模型中的应用。
Drug Metab Dispos. 2023 Oct;51(10):1403-1418. doi: 10.1124/dmd.123.001403. Epub 2023 Jul 17.
9
A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter f in Physiologically Based Pharmacokinetics.使用生理药代动力学中的分数分布参数 f 对经典肝脏清除模型进行全面扩展。
J Pharm Sci. 2024 Jan;113(1):95-117. doi: 10.1016/j.xphs.2023.05.019. Epub 2023 Jun 4.
10
Exploring the Pharmacokinetic Mysteries of the Liver: Application of Series Compartment Models of Hepatic Elimination.探索肝脏的药代动力学之谜:肝消除系列隔室模型的应用。
Drug Metab Dispos. 2023 May;51(5):618-628. doi: 10.1124/dmd.122.001190. Epub 2023 Feb 2.
J Math Biol. 1982;15(3):305-18. doi: 10.1007/BF00275690.
4
Functional implications of liver cell heterogeneity.肝细胞异质性的功能意义。
Gastroenterology. 1981 Feb;80(2):393-403.
5
Functional and anatomic heterogeneity in the liver acinus: impact on transport.
Am J Physiol. 1983 Jun;244(6):G578-82. doi: 10.1152/ajpgi.1983.244.6.G578.
6
Flow dependence of propranolol elimination in perfused rat liver.
J Pharmacol Exp Ther. 1984 Aug;230(2):474-7.
7
Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.通过普萘洛尔蛋白结合的扰动来区分离体灌注大鼠肝脏中肝药物消除的静脉平衡模型和窦状隙模型。
J Pharmacol Exp Ther. 1984 May;229(2):522-6.
8
Albumin binding and hepatic uptake: the importance of model selection.
J Pharm Sci. 1983 Oct;72(10):1232-3. doi: 10.1002/jps.2600721038.
9
Hepatic extraction of free fatty acids in pregnant and nonpregnant female rats.
J Pharm Sci. 1983 Oct;72(10):1230-2. doi: 10.1002/jps.2600721037.
10
Models of hepatic drug elimination.
J Pharm Sci. 1983 Oct;72(10):1229-30. doi: 10.1002/jps.2600721035.